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Abstract
Background: A number of recent reports published in the UK have put the quality of care of adults with
Rheumatoid Arthritis (RA) centre stage. These documents set high standards for health care professionals and
commissioning bodies that need to be implemented into routine clinical practice. We therefore have obtained the
views of recipients and providers of care in inner city settings as to what they perceive are the barriers to
providing integrated care.
Methods: We conducted focus groups and face to face interviews between 2005-8 with 79 participants (patients,
carers, specialist medical and nursing outpatient staff and general practitioners (GPs)) working in or attending three
hospitals and three primary care trusts (PCT).
Results: Three barriers were identified that stood in the way of seamless integrated care in RA from the
perspective of patients, carers, specialists and GPs: (i) early referral (e.g. ‘gate keeper’s role of GPs); (ii) limitations of
ongoing care for established RA (e.g. lack of consultation time in secondary care) and (iii) management of acute
flares (e.g. pressure on overbooked clinics).
Conclusion: This timely study of the multi-perspective views of recipients and providers of care was conducted
during the time of publications of many important reports in the United Kingdom (UK) that highlighted key
components in the provision of high quality care for adults with RA. To achieve seamless care across primary and
secondary care requires organisational changes, greater personal and professional collaboration and GP education
about RA.
Background
A number of UK national bodies and groups have
reported on the components of quality care for people
with rheumatoid arthritis (RA). Key recent reports have
been published by the National Institute for Health and
Clinical Excellence (NICE) [1], the National Audit Office
[2] and the King’s Fund [3]. These built on earlier
reports from the Arthritis and Musculoskeletal Alliance
Standards of Care (ARMA) [4] and British Society For
Rheumatology (BSR) guidelines [5,6]. These reports
overlap with the new focus on quality care throughout
the National Health Service (NHS) [7]. Long-term disor-
ders like RA require similar seamless integrated care
across the primary/secondary interface as that estab-
lished for diabetes for example [8].
We report the key findings from an extensive qualita-
tive review of services for RA provided in an inner city
environment serving an ethnically diverse and relatively
deprived population. Our principal goal was to assess
the perceived barriers that prevent the provision of
seamless integrated care across the primary and second-
ary healthcare sectors. We assessed the varying perspec-
tives of patients, carers, specialists and general
practitioners (GPs). Studying such a representative and
diverse group of patients, carers and clinicians avoids
limitations from concentrating on selected patients and
clinical staff linked to national groups.
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Participants
Focus groups and face to face interviews held between
2005-8 involved 79 participants working in or attending
three hospitals and three primary care trusts (PCTs).
PCTs were part of the NHS and provided some primary
and community services or commissioned them from
other providers, and were involved in commissioning
secondary care. These groups comprised:
a. Two patient focus groups: a purposive sample of 11
RA patients was obtained from one hospital outpatient
department; their selection was stratified by disease
duration, gender, ethnicity and age. They comprised 8
females and 3 males with a mean age of 58 years and
mean disease duration of 12 years; eight were Caucasian
and three from black and ethnic groups. One patient
refused to take part.
b. Patient interviews: a quota sample of 26 patients
was obtained from the same hospital as the focus group
participants and one other hospital outpatient depart-
ment to reflect socio-demographic characteristics and
duration of illness of the two RA clinics’ population.
They comprised 22 females and 4 males of mean age 56
years and mean disease duration ten years; 18 were Cau-
casian and eight from ethnically diverse groups. There
was no overlap in the patients between the individual
interviews and focus groups. Nine patients refused to
take part.
c. Carers interviews: the carers consisted of a conveni-
ence sample of 11 carers from two hospital outpatient
departments. They were approached by staff and the
researcher through the RA patients they were caring for.
They included five females and six males of mean age
61 years; seven were Caucasian and four from other eth-
nic groups.
d. Specialist Health Care Professionals focus group: six
representative members of one multidisciplinary team
participated, consisting of consultant rheumatologist,
consultant orthopaedic surgeon, rheumatology nurse
specialist and allied health professionals (occupational
therapist, physiotherapist and podiatrist).
e. Specialist Health Care Professionals interviews: 15
secondary care specialist staff (6 consultants, 4 specialist
registrars and 5 rheumatology nurse specialists) from
three hospitals. Eight declined participation in the study.
f. Generalist Health Care professional interviews: 13
GPs from three local PCTs.
All patients met the American College of Rheumatol-
ogy criteria for RA. Socio-demographic details of
patients and carers are summarized in Table 1. Written
consent was obtained from each participant and each
study was fully approved by the relevant local Research
Ethics and Research and Development committees.
Data Generation
The audio taped focus groups and 1:1 interviews were
carried out in private rooms using a semi structured
interview guide [9]. The interview schedules were based
on related literature [10,11] and the researchers’ experi-
ential knowledge. Focus groups and interviews took
between one to two hours.
Analysis
Interview and focus group information was transcribed
verbatim. Qualitative computer software NVivo 8 was
used to analyse and handle the data. Content and dis-
course analysis were applied [12,13], including single
counting [14] and deviant results [15]. For validation of
the data, external qualitative co-researchers, not
involved in the data gathering and analysis, cross-
checked initial codes and reached agreement with the
researchers about the codes for further data analysis. In
addition the data were also presented to two experi-
enced clinicians to assess resonance and plausibility with
their clinical experiences. To determine the significance
for routine clinical practice in an inner city setting we
specifically examined the data from all six qualitative
studies for relevance in response to the recent
publications.
Results
Through detailed examination of all the data three main
barriers to high quality care were identified. These com-
prised (i) delayed specialist referral; (ii) limitations to rou-
tine follow up and (iii) accessing care in times of need
(Table 2). Examples of matters raised by patients, carers
and healthcare professionals are summarised in Table 3.
Specialist Referral
Patients and Carers
Most patients (29/37) consulted their GPs when their
symptoms started. Many (14/37) reported frustration at
delays in specialist referral; only one patient commented
on being referred early. Some patients (4/37) reported
specialist referrals depended on positive blood tests, two
of these patients had been diagnosed within the previous
twelve months. Delayed referral was mentioned by few
carers (2/11).
Healthcare Professionals
All rheumatology specialists in the focus group (3/3)
commented on delayed referrals, noting variations in the
timing and quality of referrals. This issue did not feature
in interviews with individual specialists. Some GPs (4/
13) emphasised the need for early referral but many
(11/13) commonly waited for ‘positive blood tests’ for
rheumatoid factor before referring. Some GPs (5/13)
also waited for confirmatory responses to initial
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A number of GPs (5/13) were influenced by their per-
ceived role as ‘gate keepers’ to specialist care.
Limitations in follow up
Patients and Carers
Many patients (18/37) commented on the importance of
monitoring their RA, highlighting the need for physical
examinations together with explanations of disease pro-
gress and joint discussion of options of new treatments.
They wanted the opportunity to participate in decisions
about their care. Patients (12/37) focussed on the value
of understanding approaches by staff and developing
trusting relationship over time with nurses and doctors.
Some patients (8/37) commented critically about
insufficient time during consultations with rheumatolo-
gists. By contrast there were many positive comments
about interactions with rheumatology nurses (32/37).
Patients felt more comfortable discussing matters with
specialist nurses, who both understood their concerns
and had more time (7/37).
Patients reported organisational problems including
long waiting times in clinic (13/37), blood sampling for
disease modifying anti-rheumatic drugs (DMARDs)
monitoring (9/37), between appointments (5/37) and
clinic cancellations and postponements (2/37).
They described mixed experiences with their GPs. On
the one hand many (21/37) expressed criticisms about
GPs’ perceived lack of knowledge of RA and its up-to
date treatment (9/37). On the other hand a substantial
number of patients reported positive experience in pri-
mary care (14/37), often mentioning sympathetic
ongoing relationships (8/37). A minority preferred to
receive most care in hospital (6/37).
Carers voiced also concerns about waiting times in the
clinic (5/11), perceived limited benefits from treatment
(4/11) and difficulties with transport to the clinic (3/11).
One carer was concerned about GPs limited knowledge.
Most (6/11) commented on the importance of good
interactions with outpatient clinic staff. Carers noted
that RA had major impacts on themselves as well as on
the patients they were caring for.
Table 1 Patient and Carer Demographics
Patient Focus
(n = 11)
Individual Interviews
(n = 26)
Carers
(n = 11)
Female 82 2 5
Male 34 6
Age, mean years (range) 58 (33-70) 56 (25-85) 61 (36-74)
Disease duration, mean years (range) 12 (0.5-32) 10 (1-29) N/A
Ethnicity Caucasian 81 8 7
Afro-Caribbean 37 3
Asian 01 1
Table 2 Summary of Key Themes
Barriers Non-Professional Professional
Patients Carers Secondary Care Specialists General Practitioners
Specialist Referral ￿ Delay in referral
from primary care
￿ Delay in
referral from
primary care
￿ Delay in referral from primary
care
￿ Quality of referral influences
prioritisation
￿ Role as gatekeepers to specialist
care
￿ Need for positive blood tests
￿ Referral linked to personal
confidence and role perception
Routine follow up
and DMARD
monitoring
￿ Lack of time with
rheumatologist
￿ Cancellation and
postponement of
appointments
￿ Perceived lack of
knowledge of GPs
￿ Poor primary/
secondary care
interaction
￿ Waiting times in
clinic
￿ Transport
difficulties
￿ Perceived lack of
knowledge of GPs
￿ Poor primary/
secondary care
interaction
￿ Time pressures
￿ Paucity of follow up appointments
￿ Lack of monitoring by GPs
￿ Lack of regular review
￿ Lack of clarity of role in monitoring
Access to care in
times of need
￿ Difficulty of access
during a flare
￿ No specific
comments
￿ Seeing patients urgently impeded by
time pressures and paucity of
appointments.
￿ GPs not providing emergency care
￿ Lack of knowledge of RA treatment
￿ Preference for personal knowledge of
rheumatologist to access secondary care
urgently
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Area Patient/Carer HealthCare Professional
Specialist
Referral
I was diagnosed really soon because I put on a lot of weight and
at the time I was on a tablet to stop smoking. I thought it was
the tablets ....I went straight to the GP and he carried out the
rheumatoid blood tests. So I was diagnosed pretty early so I felt
quite lucky. (Patient 32)
’If they think it’s an inflammatory arthropathy, most GPs will send
it to the appropriate people, maybe not quickly enough.’ (
Consultant Orthopaedic Surgeon)
’I used to go to the gym so it took my GP nearly a year and a
half to find out that I had RA and it was only because I
demanded an x-ray... (Patient 37)
’So initial diagnosis is key and quick referral putting the right
things in the letter so that when we get the letter we can see
what they [GP] think it is...there’s huge variation then in that.’
(Consultant Rheumatologist)
’If you don’t do the blood test the hospital would be absolutely
overwhelmed. If everybody [patient] who thought they might
have rheumatoid we refer to hospital, the system would grind to
a halt... (GP1).
’So we normally do blood tests like RA Factor and antibodies and
when they come back and yes the suspicion is that they might
have RA, then we refer’ (GP2).
Routine
follow up
’Especially if it’s a period of time like 6 months [between
appointments], you know that’s a long time...they should give
you a thorough examination, send you for x-rays or god knows
what, just to see how you’re coping.’ (Patient 33)
’It depends what they come in with. You don’t always have
time.... I mean if they have everything at once it’s really difficult to
address every issue in that time slot. ‘(Nurse Specialist)
’He tries to help me, he is a really understanding doctor. He
understands how I feel. I can really talk to him. He knows how I
feel. I tell him where I am having the pain. I relate to him.’
(Patient 22)
’I think the follow-up in rheumatoid has changed a bit in the last
of couple of years from our perspective in that with the pressure
on follow up slots being so great, the interval between follow-
ups is much longer and it will be pushed out to 6 months or a
year’ (Consultant Rheumatologist)
’I have to wait a long while to see the doctor when I got an
appointment for a certain time. I have waited one hour and a
half, you never go in at the appointment time’. (Patient 15)
’I’d like the GPs to take on blood monitoring, I think that is a
complete waste of time for us to look at each single blood result
for 100 of 100 of patients and so I would like to have blood
monitoring with our support to be out in the community.
Patients would prefer that as well’. (Rheumatology Specialist
Registrar)
’I think sometimes the specialists haven’t got the time to give
you that long chat that you need, whereas the nurse will. You
know, not that the specialist doesn’t want to...’ (Patient 31)
’... so we sort of monitor them [RA patients] from the practice...
just doing their bloods, seeing everything is in order and there is
no sort of active flare up or anything and we are happy to do
that if we get a sort of proper protocol and guidelines in which
we can work’ (GP 10).
’My GP, I have... I think I have lost respect...he hasn’t really served
me particularly well. I have to ‘play act’ when I see a GP. So I
have to pretend that I am really ill and about to die before
anything actually happens ... I don’t have a lot of faith in them’.
(Patient 24)
’.... there is no financial incentive and actually I don’t agree with
the financial incentive, but if you suffer from an illness that is not
included in the QOF, I think there is a degree of neglect and
ahm... there is no motivation of the practice to think about that
[RA]’ (GP 4).
’Well my GPs quite good. If it wasn’t for my GP half the things he
told [advised] me what to do. If you come to the hospital, you
ask how you do this, nobody tells you.’ (Patient 30)
“In the end I got so mad with them (GP) I started shouting and I
said “ you know, I’ve got to come up here and ask you for blood
forms every month!"(Carer 8)
’Doctors... I think they get tired of me (carer) when I attend the
consultation.’ (Carer 5)
’I mean obviously the waiting times can get on your nerves.’
(Carer 11)
Access to
care in times
of need
’If the nurse thinks I am not all that good, she calls the doctor...
and he will come and see me right away’ (Patient 1)
’.....I like the patients to have better support...seeing someone in
six months...is not very helpful...they [patients] just struggle on... I
have no follow up appointments...the GPs don’t know what to do
you see, so it is a dreadful situation... we are under-resourced. I
don’t think that is the way to deliver it [health care]... knowing
that we can’t actually do that [provide emergency cover]’.
(Consultant Rheumatologist)
’Patients can now ‘choose and book’ any hospital which is
extremely confusing for GPs,... because I think it is extremely
important that the patients go to local hospitals and I am familiar
with the consultants and the system there.’ (GP 9).
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Specialists’ views (16/18) echoed patients’ experiences
about the paucity of follow up appointments and lack of
time during consultations; they found it difficult to
adopt a holistic approach with patients. They noted that
these pressures had resulted in appointments with rheu-
matologists being replaced by specialist nurse led clinics.
Most GPs (10/13) commented on their role in provid-
ing repeat prescriptions after the initial referral of
patients with RA, otherwise they are only marginally
involved in ongoing care. Only a minority (4/13)
reported they regularly reviewed patients with RA. GPs
believed they should combine clinical, administrative
and emotional support for RA patients, as part of their
comprehensive long-term care.
Few GPs (4/13) commented on the negative impact of
the Quality and Outcomes Framework (QOF). They sta-
ted it influenced their approach to chronic disease man-
agement and, as RA falls outside this framework, they
thought it reduced the priority given to RA patients in
primary care.
Access to Care in Times of Need
Patients and Carers
Patients emphasized the importance of immediate help
and support during times of flare of their RA and/or
emotional stress (14/37). They tend to approach rheu-
matology nurses first to gain access to specialists during
flare ups. Carers did not comment on this topic.
Healthcare Professionals
Most specialists (11/18) agreed that patients need
immediate access during an exacerbation of RA and that
the service should respond quickly and effectively. How-
ever, such access increased pressure on appointments
leading to overbooked clinics and long waiting times.
Most GPs (8/13) considered an important pre-requisite
for accessing secondary care was having a personal rela-
tionship with the consultant(s) and having knowledge
about him or her. These professional links helped access
to specialists during acute episodes of RA (9/13). When
such links did not exist (4/13) it limited successful
primary/secondary care integration. One GP thought this
relationship was hindered by the ‘choose and book’
system as patients might be seen in hospitals unfamiliar
to them. (Choose and Book is a national electronic
referral service which gives patients a choice of place,
date and time for their first outpatient appointment in a
hospital or clinic.)
Discussion
This qualitative study identified three key areas in which
there were perceived barriers to seamless integrated care
in RA from the perspective of patients, carers, specialists
and GPs. These are early referral, limitations of ongoing
care for established RA and management of acute flares.
The study took place during a period in which NICE
guidelines and other UK care strategies were being
developed [1-7], and therefore helps place our findings
in context. Our results are relevant as there are few
multi-perspective studies in rheumatology [16] and the
multiperspective qualitative approach is very useful to
capture the experiences of all stakeholders involved in
the treatment and care [17-20].
This qualitative study was conducted in three out-
patient clinics and three PCTs consisting of 79 partici-
pants of whom 37 were patients. It is difficult to assess
how generalisable the findings of this study are,
although patients were selected from two different
clinics. The question over whether the emerging themes
are general ones or merely represent local issues is diffi-
cult to answer although evidence from previous studies
would suggest that similar issues occur more widely,
examples include previous studies which showed delays
in referral caused by the presence or absence of positive
blood results [21,22], the need for good access and
working relationships with specialists [21,23] and the
lack of experience/knowledge of the primary care physi-
cian [23,24]. The lack of time with rheumatologists and
lack of communication between primary and secondary
care has also been noted in other parts of the world
[23].
Qualitative approaches allow patients to give first-
hand accounts of their experiences, in this case their
experience of the care provided in primary and sec-
ondary settings. By focusing on detailed descriptions
and their meaning, such in-depth accounts, from semi-
structured interviews, may uncover aspects that cannot
be readily captured by structured questionnaires and
provide information that is helpful when trying to
re-organise services. To our knowledge, no other paper
has been published which addresses the views of all
stakeholders involved in the care of RA patients.
Delay in referral was highlighted in our study, this has
also been suggested in previous guidelines, and observa-
tional studies from the UK [2,3]. Experience with both
the Norfolk Arthritis Register [25] and the Steroids in
Very Early Arthritis trial [26] have shown that it is pos-
sible to see UK patients with inflammatory arthritis in
the early stages of their disease. The possible causes of
delay in referral are complex and there may be several
explanations, such as reflecting organisational aspects;
however, alternate explanations may include patient
issues such as the disparity between actual observed and
perceived time to referral in those patients with long
disease duration, who may find it difficult to accurately
estimate any delays after such long periods. Patients
may also take some time to identify their symptoms and
hence achieve referral, which may be reflected in a
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many patients present with features that could be inter-
preted as leading to rheumatoid arthritis but, over time,
melt away and do not progress. Other publications have
suggested that people with inflammatory arthritis delay
seeking medical advice [2] which could also impact on
the time to referral to secondary care. In particular pre-
vious studies have shown that ethnicity may play a part
in the delay in people seeking help [27] as well as their
willingness to accept aggressive treatment [28]; these
observations are pertinent given the multicultural popu-
lation served by South London. However, the issue of
people delaying seeking help was not discussed by our
patients or GPs. One clear message from our research
with GPs was that they are concerned about their role
as “gatekeepers” to secondary care. This potentially cre-
ates reluctance to refer patients with possible inflamma-
tory arthritis for specialist advice and is a barrier that
needs to be removed [2].
Conclusions
There are several limitations in the ongoing management
of established RA that could be overcome by changes in
the arrangements of the service. One major issue is insuf-
ficient time in secondary care appointments so that clini-
cians do not fully address major concerns for patients.
The greater involvement of specialist nurses has been
particularly helpful [29], but is not enough by itself. The
evidence suggests that specialists should devote more
time and resources to the follow up of patients with
established RA [10]. The NHS Musculoskeletal Frame-
work [6] should assist this goal by transferring stable
musculoskeletal disorders to community based units and
allowing specialists to focus on managing RA. This will
require a re-evaluation of new to follow-up ratios as low
ratios, often considered a mark of effective care, may
actually indicate poor quality care in RA.
A second important issue is the limited knowledge
many GPs have about RA [3,23,24]. This reflects not
only the absence of musculoskeletal disorders from the
Quality and Outcomes Framework but also the dearth
of rheumatology teaching in the postgraduate training of
UK GPs [2]. Whilst some GPs provide high quality care,
this is by no means universal [3]. It is impractical to
equip all GPs with enough expertise to make significant
inputs into the management of RA patients, and the
best solution may be to make better use of those GPs
with particular expertise in the field. This has been uti-
lised in some parts of the country by the establishment
of so-called GPSIs (GPs’ with a specialist interest). Many
of these GPs could be trained within rheumatology
departments running clinics alongside consultants gain-
ing greater insight and knowledge, which can then be
transferred into the community setting.
The final key issue is the need for close collaboration
between primary and secondary care. Terminology may
hinder improvements of service as the distinction actually
lies between specialist and generalist. As RA is relatively
uncommon and GPs have limited knowledge about the
disease, we consider its care needs to be managed by spe-
cialists. However, there needs to be better links between
specialists and the community they serve and good work-
ing relationships between GPs and specialists and this
might be better served by basing specialist services within
the community. Better professional relationships could
also be established by inviting community services into
specialist centres to meet specialists and to organise
teaching sessions. These ties would need to be continu-
ally maintained and would require commitment from
both sides as it is unlikely that monetary resources would
be available through the NHS although other sources
could be sought. However, RA patients often need direct
access to X-rays and other specialist opinions. Exact solu-
tions would have to be determined at a local level
depending on issues such as travel for patients and local
community facilities. We realise that this will be a con-
troversial matter that cannot be readily resolved.
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